Acadian Asset Management
COGT icon

Acadian Asset Management’s Cogent Biosciences COGT Stock Holding History

Acadian Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Sell
10,803
-3,011
-22% -$105K ﹤0.01% 1494
2026
Q1 		$530K Sell
13,814
-1,503
-10% -$55.5K ﹤0.01% 1342
2025
Q4 		$543K Buy
+15,317
New +$431K ﹤0.01% 1287
2024
Q4 		– Sell
-3,320
Closed -$35K – 1719
2024
Q3 		$35K Buy
+3,320
New +$32.3K ﹤0.01% 1893
2021
Q2 		– Sell
-610
Closed -$5K – 2027
2021
Q1 		$5K Buy
+610
New +$5.87K ﹤0.01% 2020
2020
Q4 		– Sell
-80,759
Closed -$757K – 2218
2020
Q3 		$757K Sell
80,759
-6,203
-7% -$64.7K ﹤0.01% 1007
2020
Q2 		$161K Buy
86,962
+56,278
+183% +$104K ﹤0.01% 1563
2020
Q1 		$51K Hold
30,684
– – ﹤0.01% 1498
2019
Q4 		$88K Buy
30,684
+18,939
+161% +$77.3K ﹤0.01% 1502
2019
Q3 		$68K Buy
11,745
+3,595
+44% +$29.2K ﹤0.01% 1567
2019
Q2 		$85K Buy
8,150
+4,679
+135% +$62.3K ﹤0.01% 1397
2019
Q1 		$61K Buy
+3,471
New +$59.3K ﹤0.01% 1633

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management's COGT Position: Q2 2026 in Review

Acadian Asset Management reduced its Cogent Biosciences (COGT) stake by 22% in Q2 2026, selling an estimated $105K and leaving 10,803 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1494.

Acadian Asset Management first reported a position in COGT in Q1 2019 and has held it in 12 quarters since. The position peaked at $757K in Q3 2020. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Acadian Asset Management held 10,803 shares of Cogent Biosciences worth $416K as of Q2 2026.
  • Acadian Asset Management sold 3,011 Cogent Biosciences shares in Q2 2026, an estimated $105K.
  • Cogent Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1494 holding.
  • Acadian Asset Management first reported a position in Cogent Biosciences in Q1 2019 and has held it in 12 quarters since.
  • Acadian Asset Management's Cogent Biosciences position peaked at $757K in Q3 2020.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.